The development of antigen-specific functional T lymphocyte immunity in infants and children is an area of immunology that needs elucidation. Leukocytes from cord blood (CBL) and from PBL of children of different ages who were in the hospital for minor surgical procedures were compared with PBL from healthy adults for their ability to generate T helper cell (Th) responses assessed by in vitro proliferation and IL-2 production after stimulation with: influenza A virus (FLU); tetanus toxoid (TET); adult allogeneic PBL that were either undepleted (ALLO) or depleted ofadherent antigen presenting cells (ALLONW); and PHA. CBL generated Th responses to AL-LONW, ALLO, and PHA, but not to FLU or TET. PBL from infants between 6 and 13 mo of age responded to ALLO and PHA; none responded to FLU or ALLONW, and two of four responded weakly to TET. PBL from children between 13 and 26 mo ofage responded to all stimuli except FLU, to which only one child responded marginally. PBL from children older than 36 mo responded to all stimuli at levels comparable to those of PBL from adults.
Introduction
An understanding of the developing immune system is an important area of immunology, because it is during this period that the individual: (a) acquires the ability to distinguish self from nonself ( 1 ); (b) establishes mechanisms in the peripheral immune system to prevent potential autoimmune reactions ( 1 ); and (c) develops and expands clones of lymphocytes with immunologic memory necessary to fight infections (2, 3) . Recently, human developmental immunity has assumed particular significance, due to the increase in the number of pediatric cases of AIDS, primarily as a result of mother-to-child transmission of HIV, either by transplacental or perinatal transmission (4, 5) . Thus, it has become increasingly important to determine: which components of the immune system are functionally mature at birth; when, during postnatal development, is the human immune system capable of responding to different types of antigenic stimuli, particularly to recall antigens; and when, during development, does the ability to generate immune responses to HIV antigens appear in infected infants. Furthermore, the establishment of a timetable for the development ofT cell immunity is needed, because it could permit one to distinguish between a lack of T helper cell (Th)' and/or antigen-presenting cell (APC) function due to developmental factors versus HIV-induced defects. Studies have been reported demonstrating that neonatal PBL express high affinity IL-2 receptors and produce near adult levels of IL-2 when maximally stimulated with mitogens, but are severely defective in the production of IFN-'y and IL-4 (6) (7) (8) . Other studies have reported that neonatal T lymphocytes are almost entirely ofthe naive phenotype (2, 3, 9) .
In this study we have assessed in vitro-generated Th responses by cord blood leukocytes (CBL) and by PBL from pediatric donors of different ages to a series of T cell stimuli previously used to analyze Th function in HIV-infected (HIV+) (10) and uninfected (HIV-) (11) adults. These responses include IL-2 production and proliferation to influenza A virus (FLU), tetanus toxoid (TET), allogeneic PBL depleted of antigen-presenting cells by nylon wool adherence (AL-LONW), undepleted allogeneic PBL (ALLO), and PHA. This panel of stimuli was chosen because Th responses to FLU, TET, and ALLONW are HLA-self-restricted, and require antigen processing and presentation by autologous APC ( 11). It (11). These stimuli were also selected for study in young children because we have previously reported that: (a) PBL from both adult (10) and pediatric (12) HIV + individuals exhibit a spectrum of Th defects to this panel of T cell stimuli that is predictive for AIDS progression in adults (10, 13) and for susceptibility to opportunistic and bacterial infections in children (12); and (b) different patterns of function of the Th pathways are predictive for human solid organ allograft rejection ( 14) . The results of this study will be relevant for assessing Th and antigen presenting cell functions that are required for immunologic maturation in infants, and may be important for vaccination and modulation of immunity in infants and children.
Methods
In vitro assayfor Thfunction. The 24 cord bloods were obtained from neonates that ranged from 28 to 42 wks in gestation (median of 39 wks; 8 of the 24 were < 38 wks). Blood was obtained immediately after delivery by isolating a segment of umbilical cord and performing cordocentesis with a sterile needle. In this manner, -7 ml of newborn venous blood was collected into a tube containing 200 USP units of heparin (Elkins-Sinn, Inc., Cherry Hill, NJ). All cord blood samples were obtained from healthy deliveries. A maximum of 3 ml of whole blood was collected from infants < 27 mo of age ( 15 patients), and 6 ml was collected from children between 36 mo and 14 yr of age ( 13 patients) by routine phlebotomy in conjunction with preoperative blood tests. These children had been admitted to Children's National Medical Center for minor surgical procedures, which included inguinal hernia repair, tonsilectomy, myringotomy, and strabismus eye surgery. There was no evidence of concurrent infections in these infants. A protocol and consent form for obtaining this volume ofblood from the children, as well as the newborns, was reviewed and approved by the Institutional Review Boards ofthe Fairfax Hospital, the Children's National Medical Center, and the National Cancer Institute. Due to constraints imposed by the Institutional Review Boards, blood from infants younger than 6 mo of age could not be obtained in quantities sufficient to perform experiments, and accrual of infants for the study was limited to the 13 presented in the report. Blood from adult donors was obtained as a buffy coat derived from donors undergoing plasmapheresis in the Department of Transfusion Medicine, National Institutes of Health.
The mononuclear cell fraction was obtained using lymphocyte separation medium (Organon Teknika Corp., Durham, NC), washed twice in PBS, and the number of viable cells was determined by trypan blue exclusion. CBL and PBL were resuspended at 3 x 106/ml in RPMI 1640 (Gibco Laboratories, Grand Island, NY) containing 0.5% penicillin and 1% glutamine. For both the IL-2 production and the proliferation assays, 0. Pooled human plasma (5%) was added to each well, and for IL-2 production studies, the anti-IL-2 receptor antibody, monoclonal anti-TAC, (a gift from Dr. T. A. Waldmann, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD) was added at the initiation ofculture at a concentration of 5 ,g/ml to block IL-2 consumption (10, 11) . Supernatants of the cultures were har- [3H]thymidine and harvested 18 h later. All thymidine pulsed cultures were harvested using a harvesting system (TomTec, Inc., New Haven, CT) and the samples were counted using a plate spectrometer (Pharmacia LKB Biotechnology, Piscataway, NJ). For both the IL-2 and proliferative responses, results are expressed as mean cpm for triplicate wells. Standard errors were consistently < 10% of the mean values. The stimulation index was determined as the ratio ofcpm from stimulated cultures to that ofunstimulated cultures. Standard titration curves were determined using recombinant IL-2 (Cetus Corp., Emoryville, CA). However, we were not able to calculate accurately IL-2 units because many of the titration curves generated by unresponsive PBL from young children were flat and not parallel to the standard curves or to the curves generated by PBL from control donors. Therefore Figs. 1 and 5 present complete titration curves, and Fig. 2 shows a dot plot at the highest supernatant concentration of 1:2. A response was determined to be positive if the cpm from stimulated wells exceeded the mean background (unstimulated) cpm observed by three standard deviations (10) . We have compared and include both IL-2 production and proliferative assays to verify results obtained from a limited number of infants and because of the fact that proliferative responses have been more often reported than IL-2 production data.
Depletion of adherent cells and CD8' cells. Adherent APC were removed by a two-step process of plastic adherence for 30 min (at 370C, 7% C02, and 2% human plasma), followed by passage of the cells over a nylon wool column. The depleted cell population contained < 5% monocytes as determined by flow cytometry staining with FITC-conjugated anti-human monocyte/mAb, Leu-M3 (Becton Dickinson, Mountain View, CA) (1 1, 15) . Enrichment of APC was achieved by centrifugation of PBL over a SepracelO gradient (Sepratech Corp., Oklahoma City, OK) at 1,500 rpm for 20 min at 220C. The top band was removed, washed, and irradiated with 50 Gy before use as APC. This fraction contained 90-96% monocytes as determined by flow staining with Leu-M3 (data not shown).
CD8 + T cells were negatively selected using the panning technique described elsewhere (7) . Cells were first incubated with anti-CD8 (Leu2a) murine mAb (Becton Dickinson), washed, and incubated for 2 h at 4°C in petri dishes precoated with the IgG fraction ofgoat anti-mouse IgG (Cappel Laboratories, Malvern, PA). After 2 h, nonadherent cells were collected, washed, and adjusted to the desired concentration. Flow cytometric analysis of panned cells by this technique indicated that they consistently contained < 5% of the depleted population of cells (1 1, 15) . This determination was based on staining ofthe panned cells with FITC-labeled Leu-2a, Leu-3a, or Leu-M3 mAbs, as well as FITC-labeled F(ab')2 fragment of IgG fraction ofgoat anti-mouse IgG antibody (Cappel Laboratories) to detect cells that bound antibody but were not depleted.
Samples ofCBL from deliveries ofthree male and one female (control) infants were stimulated with PHA in RPMI 1640 media containing 20% fetal bovine serum. After 72 h of culture, the chromosomes were stained with Giemsa-trypan, and 150 metaphase spreads were analyzed microscopically for each ofthe four samples (by an individual who did not know the sex of the infants) for the number of X and Y chromosomes.
Results
Analysis of T helper cell function. T helper cell responses assessed by IL-2 production to FLU, TET, ALLONW, ALLO, and PHA are shown in Fig. 1 for individuals of different ages who are representative ofthe groups that we have studied. CBL from a neonate responded to ALLONW, ALLO, and PHA, but not to FLU or TET (A). PBL from an 11-mo-old infant re- sponded to ALLO and PHA, but not to FLU, TET, or AL-LONW (B). PBL from a 24-mo-old-child responded to all stimuli except to FLU (C). PBL from a 6-yr-old child responded to all stimuli (D) at a level comparable to PBL from an adult (E). Thus, some remarkable Th functional differences were observed between adjacent panels in that: (a) CBL responded to ALLONW, whereas PBL for the 11-mo-old infant did not (compare A and B); (b) PBL from the 24-mo-old child responded to TET and ALLONW, whereas PBL from the 11-mo-old infant did not (compare B and C); and (c) PBL from the 6-yr-old child responded to all stimuli, whereas PBL from the 24-mo-old failed to respond to FLU (compare C and D).
The mean cpm for IL-2 production generated by the IL-2-sensitive CTLL cell line (at a culture supernatant dilution of 1:2) by CBL and PBL from all samples tested are summarized as a dot plot in Fig. 2 . Similar to the IL-2 titration curves shown for representative individuals in Fig. 1 , CBL (from 16-24 samples) responded to ALLONW, ALLO, and PHA, but not to FLU or TET. One CBL sample generated a marginal response to TET. PBL from the four infants 12 mo of age or less responded to ALLO and PHA, but not to FLU or ALLONW. Two of the four samples responded weakly to TET. PBL from the 13-26-mo-old children responded strongly to all stimuli except FLU. PBL from the children 36 mo of age or older generated strong responses to all stimuli, as did PBL from nine adults.
We have also tested Th responses to these five stimuli by proliferation. The cpm data and stimulation indices of representative individuals from the five different age groups are shown in Fig. 3 . (These are not the same representative individuals used for illustration in Fig. 1.) As was observed for IL-2 production: (a) CBL responded to ALLONW, ALLO, and PHA, but not to FLU or TET (A); (b) PBL from the 11-moold infant responded to ALLO and PHA, but not FLU, TET or ALLONW; (c) PBL from the 26-mo-old child responded strongly to all stimuli except FLU, for which the response was weak (C); and (d) PBL from the 4-yr-old child responded to all stimuli (D), as did PBL from the adult (E).
The mean stimulation indices for proliferative responses to the five stimuli are shown in Fig. 4 , and confirm the data ofthe three preceding figures. Thus, proliferative responses to FLU were: (a) potent in PBL from children 36 mo of age or older and in adults: (b) weak in children between the ages of 13 and 26 mo; and (c) negative in infants 6-12 mo ofage, and in CBL (A). Proliferative responses to TET were: (a) marginal by PBL from infants 6-12 mo ofage and negative by CBL; (b) stronger in 13-26-mo-old infants than the response to FLU; and (c) were potent and equivalent to adult responses in children older than 36 mo of age (B). The proliferative responses to AL-LONW were potent and indistinguishable in CBL and in PBL from children older than 36 mo and adults. PBL from infants between the ages of 6 and 12 mo were unresponsive, and PBL from 13-26-mo-old infants were weakly responsive to AL-LONW (C). Proliferative responses by PBL from all groups were strong to ALLO and PHA, although the responses by CBL and PBL from 6-12-mo-old infants were weaker than those from the older groups (D and E).
To exclude the possibility that our results with CBL were artificial due to maternal lymphocyte contamination of CBL, cytogenetic analysis of metaphase spreads of PHA-stimulated CBL from deliveries ofmale offspring were performed to determine whether the CBL were contaminated with maternal lymphocytes. All Fig. 6 , in which we have summarized the IL-2 titration data by a dot plot for the 1:2 supernatant dilution. These results indicate that CBL (A and B) and PBL from infants and children older than 13 mo (E and F) can stimulate PBL from an unrelated adult donor, irrespective ofwhether the responder PBL were depleted of APC. Two exceptions were noted in which APC-depleted PBL from an 18-and a 24-mo- Figs. 1-4) suggests an event that involves maturation of the infants' APC function that has occurred by 13 mo of age. This maturation event could be mediated by cytokine(s), and might involve an increase in the expression of HLA (possibly class II) on APC. Such a mechanism could also account for the unexpected observation that CBL are responsive to ALLONW, whereas PBL from infants less than 13 mo of age are unresponsive. This difference in response to ALLONW that unexpectedly declined after birth could be due to maternal cytokine influences on APC function of CBL, which might elevate HLA antigen expression on APC at the time ofbirth, but which could be lost with time. Other studies have reported that monocytes from newborns: (a) can process and present antigens as well as monocytes from adults ( 16); and (b) express surface Ia antigens, produce interleukin 1, and present bacterial antigens as well as do monocytes from adults ( 17) . Such studies have not tested for the possibility of a decline in APC function after birth. The return of Th function in response to ALLONW at 1 I yr of age could reflect endogenous APC maturation by the infant. It is unlikely that the response ofCBL to ALLONW was due to contaminating maternal PBL, because no female cells were observed in 450 methaphases examined from three male births.
The present study is also important in that it establishes a timetable for the development of T helper cell immune responses to infectious agents. Without the knowledge of this sequence of maturational events, it may not be possible to distinguish between an absence of T helper immunity in infants that is due to lack of cell development versus HIV-induced immune dysfunction. It is also noteworthy that the CBL from 28-wk to full-term deliveries all exhibited similar patterns of immune maturation. This observation suggests that T cell immune potential of28-wk CBL is as mature for the stimuli tested as that of full-term infants.
Neonatal lymphocytes have been reported to be defective in IFN-y and in IL-4 production, but not in IL-2 production (2, 3, 6, 7, 18, 19) . Our detection ofa defect in IL-2 production which is selective for responses to recall antigens and to self-APC processed alloantigens (ALLONW) but not to stronger stimuli such as ALLO or PHA further supports a deficiency in HLA self-restricted Th that is dependent on functional APC responses. The failure of other studies to detect IL-2 defects (6-8) is likely due to the potent stimuli used to activate T cells in those studies. Thus, to appropriately assess functional T cell development that is relevant for infection, the immunologic parameters tested should include responses to recall antigens or APC-depleted, allogeneic adult APC, none of which provide additional costimulatory factors. Furthermore, stimulation of infant PBL with APC-depleted, allogeneic adult APC provides a test ofthe infants' APC function without the complication of requiring primed T cells for responses to recall antigens.
This study demonstrates the importance of using a panel of immune stimuli to evaluate immune maturation that can distinguish between defects in helper, antigen presenting, and memory function. Based on our findings, it is unlikely that PBL from infants will be able to consistently respond by in vitro Th tests to recall antigens until -12 mo of age for antigens such as TET, to which the infants have been immunized. There may be even a longer delay in Th function to recall antigens for which infants have not be intentionally immunized such as FLU. There is an alternative possibility for infants exposed to antigens in utero. It is possible that T cells in utero (as well as after birth) are sufficiently mature to respond to recall antigens and to develop memory markers if the APC are mature enough to process and present antigen. Our findings that CBL after as short as 28 wk ofgestation can respond to ALLONW (which does not depend on memory), and that this potential is absent in infants between 6 and 12 mo ofage, raises the possibility that these putative maturational effects of maternal cytokines would permit efficient immunization for T cell immunity in utero or perinatally, but not necessarily during the first year of infancy.
It should be noted that, due to accrual restrictions, this report has been necessarily limited to the study of four infants between the ages of 6 and 12 mo, and to nine between 12 and 24 mo ofage. Due to the small number ofinfants studied, it will be important that these findings be verified by other investigators.
It may be relevant that we have recently detected HIV-specific Th response in the CBL after delivery of -40% ofinfants from HIV seropositive mothers (Clerici M., et al., manuscript submitted for publication). The findings of the present report may provide insights into perinatal T cell immunity that may eventually permit in utero immunization against infectious agents to which certain newborn infants would be at risk. Such an approach could be particularly useful in pregnant women infected with HIV.
